Absolute barrier isolation and antibiotics in the treatment of experimental burn wound sepsis.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000985:Antisepsis; D002056:Burns / Q000097:blood / Q000150:complications* / Q000382:microbiology / Q000628:therapy; D004926:Escherichia coli / Q000302:isolation & purification; D005243:Feces / Q000382:microbiology; D005260:Female; D011113:Polymyxins / Q000627:therapeutic use; D011511:Proteus / Q000302:isolation & purification; D011549:Pseudomonas / Q000302:isolation & purification; D011552:Pseudomonas Infections / Q000628:therapy; D051381:Rats; D013210:Staphylococcus / Q000302:isolation & purification; D013449:Sulfonamides / Q000627:therapeutic use; D014946:Wound Infection / Q000628:therapy*
D000900:Anti-Bacterial Agents; D011113:Polymyxins; D013449:Sulfonamides